July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Giulio Francolini: QoL data from DART trial
May 4, 2025, 12:33

Giulio Francolini: QoL data from DART trial

Giulio Francolini, Radiation Oncologist at Careggi University Hospital, shared a post on X:

“QoL data from DART trial (SBRT+/- darolutamide in oligorec. pCa).

Global health and most QoL subdomains remained stable in both arms over the 24-week period.

More fatigue and hormonal treatment-related symptoms were observed in the SBRT and DARO arm, ESTRO.”

The post presents updated findings from the DART trial, indicating stable quality of life across both study arms over 24 weeks.

However, patients receiving both SBRT and darolutamide experienced increased fatigue and hormonal symptoms.

Giulio Francolini: QoL data from DART trial

Stay tuned to OncoDaily for continued coverage and updates from ESTRO25.